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The present study investigated whether whole-body cryotherapy (WBC) procedures could potentially have more beneficial effects
on index of BASDAI and BASFI, pain intensity, and spine mobility parameters: Ott test, modified Schober test, chest expansion
in ankylosing spondylitis (AS) patients, than kinesiotherapy procedures used separately. AS patients were exposed to a cycle of
WBC procedures lasting 3 minutes a day, with a subsequent 60 minutes of kinesiotherapy or 60 minutes of kinesiotherapy only,
for 10 consecutive days excluding weekend. After the completion of the cycle of WBC procedures with subsequent kinesiotherapy
in the AS patients, BASDAI index decreased about 40% in comparison with the input value, whereas in the group of patients who
received only kinesiotherapy it decreased only about 15% in comparison with the input value. After the completion of the treatment
in the WBC group, BASFI index decreased about 30% in comparison with the input value, whereas in the kinesiotherapy group it
only decreased about 16% in comparison with the input value. The important conclusion was that, in WBC group with subsequent
kinesiotherapy, we observed on average about twice better results than in the group treated only by kinesiotherapy.
1. Introduction
Ankylosing spondylitis (AS) is a chronic, usually progressive
inflammatory rheumatic disease affecting primarily the axial
skeleton and sacroiliac joints. It usually begins in the second
or third decade of life and tends to occur more often in
males with a male to female ratio of roughly 2 to 1. The
overall prevalence is between 0.1% and 1.4%. Chronic spinal
inflammation can develop a complete fusion of the vertebrae,
a process called ankylosis, which causes total loss of mobility
of the spine. In addition, AS may affect peripheral joints, the
skin, eyes, bowel, or lungs [1].
The main symptoms of the disease are pain and stiffness
in the low back, upper buttock area, neck, and the remaining
regions of the spine, which may lead to structural and
functional impairments [2].
Although over the last years a revolution in the treatment
of AS has taken place, in terms of improved understanding
of disease pathophysiology, still in the 21st century, phys-
iotherapy plays very important role and is recommended
as a cornerstone in the management of AS, together with
medication [3–5].
The primary goals of physiotherapy of the AS patient
are to improve mobility and strength, prevent or decrease
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Table 1: Demographic data of the study subjects.
Characteristic WBC group with subsequent kinesiotherapy (𝑛 = 32) Kinesiotherapy group (𝑛 = 16) 𝑝 value
Age, years, mean (SD) 46.03 ± 1.20 46.63 ± 1.50 0.095
Gender M/F 32/0 16/0 1.00
BMI, kg/m2, mean (SD) 24.1 ± 4.2 23.9 ± 5.8 0.564
Smoking (yes/no) 0/32 0/16 1.00
BASDAI index 5.39 ± 1,64 5.28 ± 1.71 0.767
BASFI index 5.18 ± 2.25 5.01 ± 2.06 0.965
Medication
DMARD (yes/no) 0/32 0/16 1.00
Biological agents (yes/no) 0/32 0/16 1.00
NSAID (yes/no) 32/0 16/0 1.00
SD: standard deviation; BMI: body mass index; BASDAI: the Bath Ankylosing Spondylitis Diseases Activity Index; BASFI: the Bath Ankylosing Spondylitis
Functional Index; NSAID: nonsteroidal anti-inflammatory drug, DMARD: disease-modifying antirheumatic drug.
spinal deformity, improve chest expansion, reduce pain, and
improve one’s overall function and quality of life [6].
Recent studies have shown that a combination of phar-
macological treatment and physical therapy gave synergetic
effects and produced positive benefits on pain, function, and
health-related quality of life in the AS patients [7–9].
One of the most efficient methods of physical medicine
used in the treatment of many diseases of the locomotor
system is cryotherapy using extremely low temperatures
(below −100∘C) applied for a short time (2-3 minutes) to
stimulate physiological reactions of the human organism,
in order to make more effective pharmacological treatment
and kinesiotherapy [10]. Cryotherapy can be used as local
cryotherapy and whole-body cryotherapy. The action of
cryogenic temperatures causes in human organism several
favorable and physiological reactions such as analgesic effect,
neuromuscular effect, anti-inflammatory and antioedema-
tous effect, and circulatory effect [11, 12].
Cryogenic temperatures applied for whole-body apart
from aforementioned effects have also significant influence
on psyche and endocrine and immune system [13–15].
The studies show that WBC procedures in AS patients
do not influence ejection fraction, late ventricular potentials,
and QT dispersion in patients without significant pathology
of circulatory system [16, 17].
In addition cryogenic temperatures applied for whole
body of AS patients have beneficial influence on adaptive
processes of vegetative nervous system [18], profile lipid [19]
aswell as antioxidant status [20, 21], decrease of inflammatory
process [22], and improvement of rheological blood proper-
ties [23].
2. Materials and Methods
2.1. Participants. The study protocol has been reviewed
and approved by the Bioethical Committee of the Medical
University of Silesia in Katowice (permission no. NN-6501-
93/I/07), and all analyzed patients were informed about trial
and gave written consent for inclusion in the study. All
clinical investigations have been conducted according to the
principles expressed in the Declaration of Helsinki (1964).
The study involved 48 nonsmoking male patients with
ankylosing spondylitis who were divided by the physician
into two groups with allocation ratio 2 : 1: 32 patients exposed
to whole-body cryotherapy procedures with subsequent
kinesiotherapy (WBC group, mean age 46.03 ± 1.20 years)
and 16 men exposed only to kinesiotherapy procedures
(kinesiotherapy group, mean age 46.63 ± 1.50 years), with
no significant difference in mean age and body mass index
between them.
The enrolment to the study was performed in the group
of succeeding male patients, with definite diagnosis of AS
who did not suffer from any other diseases, had no asso-
ciated pathologies, and whose attending physician did not
apply disease modifying antirheumatic drugs (DMARDs),
biologic agents, or steroids. The AS patients were treated
with NSAIDs, whose doses were not altered in the research
course. All patients included in the trial fulfilled themodified
New York Criteria for definite diagnosis of AS, which serve
as the basis for the ASAS/EULAR recommendations [24].
Final selection to the study included only patients HLA
B27 positive, who exhibited II and III radiographic grade
of sacroiliac joint disease, who attended consulting unit in
Health Resort in the period of subsidence of acute clinical
symptoms, in order to qualify for sanatorium treatment
(physiotherapy). The demographic data of the study subjects
are shown in Table 1.
Before the study each patientwas examined by a physician
to exclude any coexisting diseases as well as any contraindi-
cations for whole-body cryotherapy procedures. Prior to
the study a resting electrocardiogram was performed on all
patients, and before each session of cryotherapy the blood
pressure was measured in all the patients.
2.1.1.Whole-BodyCryotherapy andKinesiotherapy Procedures.
Depending on the group, the AS patients were exposed
to a cycle of whole-body cryotherapy (WBC) procedures
lasting 3 minutes a day, with a subsequent 60 minutes of
kinesiotherapy, or 60 minutes of kinesiotherapy only, for 10
consecutive days excluding weekend.
Thewhole-body cryotherapy procedures were performed
in a liquid nitrogen cooled cryogenic chamber (CR 2000)
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(produced by Creator, Poland), which consists of two com-
partments: the antechamber and the proper chamber con-
nected by an internal door. In the trial the temperature in
the antechamber was −60∘C, whereas in the proper chamber
it reached −120∘C. After a 30-second adaptation process in
the antechamber, the subjects were exposed to cryogenic
temperatures for 3 minutes in the proper chamber. During
the WBC procedure, all patients were dressed in swimsuits,
cotton socks and gloves, and wooden shoes, whereas their
mouths and noses were protected by surgical masks and
their ears by ear-protectors. All jewellery, glasses, and contact
lenses were removed before entry into the chamber. During
the WBC procedure the subjects were walking round the
chamber without touching each other.
Immediately after leaving the cryogenic chamber and
changing clothes and shoes (for track-suits and trainers),
the AS patients underwent 1-hour long kinesiotherapy. The
program of kinesiotherapy was the same for all patients in
both groups. Kinesiotherapy procedures included range-of-
motion exercise of the spine and major joints (including the
ankle, knee, hip, wrist, elbow, and shoulder). Chest expansion
andbreathing exerciseswere also included.Apart from range-
of-motion exercise, the AS patients received strengthening
exercise of the muscles of the major joints (including the
ankle, knee, hip, wrist, elbow, shoulder, thoracolumbar spine,
and cervical spine) as well as aerobic exercise (including
cycling and fast walking).
All patients completed the study and no complications or
side effects related to the WBC procedures were observed.
2.2. Assessments. The primary outcome measures were BAS-
DAI and BASFI index. Secondary measures included pain
intensity and chosen spine mobility parameters.
On the first day before the treatment cycle ofWBC and/or
kinesiotherapy and on the first day after treatment com-
pletion, the following parameters were estimated: the Bath
Ankylosing Spondylitis Diseases Activity Index (BASDAI),
the Bath Ankylosing Spondylitis Functional Index (BASFI),
and pain intensity by means of 10-point visual analogue
scale (VAS). Participants’ spinal mobility was also examined
through Ott test, modified Schober test, and chest expansion.
The BASDAI has six questions related to fatigue, back
pain, peripheral pain, peripheral swelling, local tenderness,
and morning stiffness (degree and length). Other than the
item relating to morning stiffness, all questions are scored
from 0 (none) to 10 (very severe) using a visual analogue scale
(VAS). A sum score was calculated as mean of two morning
stiffness items and the four remaining items [25].
The BASFI is the mean score of ten questions addressing
functional limitations and the level of physical activity at
home and work, assessed on VAS scales (0 = easy, 10 =
impossible) [26].
Ott test measures the range of motion of the tho-
racic spine. Patient standing and measurement made 30 cm
inferior to the C7 spinous process. The measurement was
repeated with patient in full forward flexion. An increase of
less than 2 cm suggests decreased thoracic spinal mobility
[27].
Modified Schober test measures the range of motion of
the lumbar spine. Patient standing and measurements made
10 cm above and 5 cm below the lumbosacral junction (iliac
crest line). The measurement was repeated with patient in
full forward flexion. An increase of less than 6 cm suggests
decreased lumbar spinal mobility [27].
The subject’s chest expansion was taken in standing
positionwith the feet 5 cmapart and arms elevated.Theupper
limbs at the sides with the shoulder abducted the elbow in
semiflexion, the wrist extended, and the thumb abducted
with the web between the thumb and the first fingers placed
on the level of the iliac crest.The chest expansionwas taken as
the change in circumference of the patient’s chest at the level
of the 4th intercostal space at the end of forced inspiration
minus thoracic circumference at the end of forced expiration.
Limitation of chest expansion is where the patient’s measure
recorded in centimeters is less than the average normal value
by a minimum of 2.5 cm correcting for age and gender [28].
2.3. Statistical Analysis. Statistical analysis was undertaken
using the statistical package of Statistica 10 Pl software. For
each parameter the indicators of the descriptive statisticswere
determined (mean value and standard deviation SD). The
normality of the data distribution was checked using Shap-
iro-Wilk’s test, while the homogeneity of the variance was
verified with the use of Levene’s test. In order to compare the
differences between the initial values of particular laboratory
parameters and values after the end of a cycle of treatment
procedures in both groups of subjects, a dependent sample
Student’s 𝑡-test when homogeneity of variances and normal-
ity of distribution have been fulfilled, otherwise Wilcoxon
signed-rank test was used. On the other hand in the case
of independent (unpaired) samples the 𝑡-test or Mann-
Whitney 𝑈 test has been used which was also dependent on
homogeneity of variances and normality of distribution.
Differences at a significance level of𝑝 < 0.05were consid-
ered as statistically significant.
3. Results
The obtained results are shown in Figures 1–6.
After the completion of the treatment in both studied
groups, statistically significant improvement in the values of
all examined parameters was noted.
After the completion of treatment in AS patients who
underwent whole body cryotherapy procedures with subse-
quent kinesiotherapy (WBC group), a statistically significant
decrease in BASDAI index (5.39±1.64 and 3.24±0.90 before
and after therapy, resp., 𝑝 < 0.001) (Figure 1(a)), BASFI index
(5.18 ± 2.25 and 3.86 ± 2.1790 before and after therapy, resp.,
𝑝 < 0.001) (Figure 2(a)), and pain VAS score (5.34 ± 1.58
and 2.86 ± 1.28 before and after therapy, resp., 𝑝 < 0.001)
(Figure 3(a)) and a statistically significant increase in Ott test
(1.11 ± 0.47 and 1.59 ± 0.45 before and after therapy, resp.,
𝑝 < 0.001) (Figure 4(a)), modified Schober test (1.47 ± 0.99
and 2.23 ± 1.00 before and after therapy, resp., 𝑝 < 0.001)
(Figure 5(a)), and chest expansion (1.92±0.98 and 2.63±1.00
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Figure 1: Comparison of BASDAI index before and after a cycle of whole-body cryotherapy (WBC) with subsequent kinesiotherapy
procedures (a), before and after only a cycle of kinesiotherapy procedures (b), and BASDAI index change in whole-body cryotherapy and
kinesiotherapy groups (c) obtained for patients suffering from AS.
before and after therapy, resp., 𝑝 < 0.001) (Figure 6(a)) were
obtained.
After the completion of treatment in AS patients who
underwent only the kinesiotherapy procedures (kinesiother-
apy group), a statistically significant decrease in BASDAI
index (5.28 ± 1.71 and 4.53 ± 1.62 before and after therapy,
resp., 𝑝 < 0.001) (Figure 1(b)), BASFI index (5.01 ± 2.06
and 4.35 ± 2.23 before and after therapy, resp., 𝑝 < 0.001)
(Figure 2(b)), and pain VAS score (5.00±1.63 and 4.09±1.90
before and after therapy, resp., 𝑝 < 0.01) (Figure 3(b)) and a
statistically significant increase in Ott test (1.16 ± 0.57 and
1.38 ± 0.62 before and after therapy, resp., 𝑝 < 0.05) (Figure
4(b)),modified Schober test (1.49±0.95 and 1.71±0.98 before
and after therapy, resp., 𝑝 < 0.01) (Figure 5(b)), and chest
expansion (2.34±1.26 and 2.75±1.21 before and after therapy,
resp., 𝑝 < 0.001) (Figure 6(b)) were also observed.
However, in WBC group the examined parameter
changes were significantly higher than in kinesiotherapy
group: BASDAI change (−2.15 ± 1.24 in WBC group versus
−0.74±0.34 in kinesiotherapy group,𝑝 < 0.001) (Figure 1(c)),
BASFI change (−1.38±1.03 inWBC group versus−0.66±0.39
in kinesiotherapy group, 𝑝 < 0.001) (Figure 2(c)), pain VAS
score change (−2.48 ± 1.79 in WBC group versus −0.91 ±
0.74 in kinesiotherapy group, 𝑝 < 0.001) (Figure 3(c)), Ott
test change (0.48 ± 0.24 in WBC group versus 0.22 ± 0.31
in kinesiotherapy group, 𝑝 < 0.01) (Figure 4(c)), modified
Schober test change (0.77 ± 0.31 in WBC group versus 0.21 ±
0.24 in kinesiotherapy group, 𝑝 < 0.001) (Figure 5(c)), and
chest expansion change (0.70 ± 0.25 in WBC group versus
0.41 ± 0.27 in kinesiotherapy group, 𝑝 < 0.01) (Figure 6(c)).
4. Discussion
Theavailable professional literature lacks studies assessing the
influence of whole-body cryotherapy on AS patients, besides
our own studies.
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Figure 2: Comparison of BASFI index before and after a cycle of whole-body cryotherapy (WBC)with subsequent kinesiotherapy procedures
(a), before and after only a cycle of kinesiotherapy procedures (b), and BASFI index change in whole-body cryotherapy and kinesiotherapy
groups (c) obtained for patients suffering from AS.
One of the most significant effects of cryogenic tem-
peratures is the analgesic effect connected with influence of
low temperatures on endocrine system (increased secretion
of 𝛽-endorphins), nervous system (functional disconnec-
tion of sensory receptors and their connections with pro-
prioreceptors, release of conductivity in slowly conductive
fibers, and selecting impulses coming to nervous system,
mechanism of “control gates”), and metabolic action (among
others decreased concentrations of histamine and lactate in
inflammatory changed tissues) [11, 29, 30].
In the study [31] AS patients assessed subjectively the
WBC procedures effects by means of a questionnaire. The
WBCprocedures were performed in cryogenic chamber with
cold retention. In cited study the significant improvement
concerned mainly the reduction of the intensity and fre-
quency of pain occurring as well as relaxation and improve-
ment in the quality of falling asleep and sleep.
In our own study [32] we showed that in AS patients
WBC procedures performed in cryogenic chamber with cold
retention caused the reduction of pain intensity by 46% in
comparison with the input value, whereas in the group of the
patients who received only kinesiotherapy the pain intensity
reduction amounted only to 18%.
In the presented study we observed similar results. The
pain intensity decreased about 43% in the WBC group,
whereas in kinesiotherapy group the decrease was only about
21%.
BASDAI index estimates the disease activity by evalu-
ation of fatigue, axial pain, peripheral pain, stiffness, and
enthesopathy in the AS patients. It is a quick and simple
index and demonstrates a sensitivity to change within a short
period of time as well as statistically significant (𝑝 < 0.001)
reliability. The value of BASDAI index above 4 means that
the disease is in an active period [25]. Before the trial in
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Figure 3: Comparison of pain VAS score before and after a cycle of whole-body cryotherapy (WBC) with subsequent kinesiotherapy
procedures (a), before and after only a cycle of kinesiotherapy procedures (b), and VAS score change in whole-body cryotherapy and
kinesiotherapy groups (c) obtained for patients suffering from AS.
both examined groups the value of BASDAI index was above
4. After the completion of cycle of whole-body cryotherapy
procedureswith subsequent kinesiotherapy in theASpatients
it decreased about 40% in comparison with the input value,
whereas in the group of the patients who received only
kinesiotherapy the BASDAI index decreased about 15% in
comparison with the input value.
Moreover, after the completion of the treatment only in
the WBC group its value was below 4 (inactive disease).
After pain and stiffness, one of the most important
complaints of patients with AS is disability. The BASFI index
determines the degree of functional limitation in the AS
patients. The first 8 questions evaluate activities related to
functional anatomical limitations due to the course of this
inflammatory disease. The final 2 questions evaluate the
patients’ ability to cope with everyday life. Its sensitivity and
reliability are similar to the BASDAI index [26]. As in the
case of BASDAI index, the BASFI index value was above 4
in both studied groups. After completion of the treatment
in the WBC group the value of BASFI index decreased
about 30% in comparison with the input value, whereas in
the kinesiotherapy group it only decreased about 16% in
comparison with the input value. Moreover, similar to the
BASDAI index, after the completion of the treatment only in
the WBC group its value was below 4 (inactive disease).
In WBC group Ott test, modified Schober test, and
chest expansion increased about 60%, 83%, and 53% in
comparison to the input value, whereas in the kinesiotherapy
group Ott test, modified Schober test, and chest expansion
increased only about 26%, 16%, and 26% in comparison to
the input value. We observed similar results in AS patients
who underwent WBC procedures in the cryogenic chamber
with cold retention [33].
Whole-body cryotherapy with subsequent kinesiother-
apy effects in AS patients was explicitly better compared
to the group of patients who received only kinesiotherapy.
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Figure 4: Comparison ofOtt test (cm) before and after a cycle of whole-body cryotherapy (WBC)with subsequent kinesiotherapy procedures
(a), before and after only a cycle of kinesiotherapy procedures (b), and Ott test change in whole-body cryotherapy and kinesiotherapy groups
(c) obtained for patients suffering from AS.
Beneficial effect of whole-body cryotherapy procedures on
the value of the index BASDAI and BASFI and parameters of
the spine mobility in the AS patients is mainly due to its anti-
inflammatory, neuromuscular, and antioedematous as well as
aforementioned analgesic action.
Anti-inflammatory effect of WBC procedures may arise
both from the impact of cryogenic temperatures on secre-
tion of mediators of inflammation and on the prooxidant-
antioxidant balance and stabilization of lysosomemembranes
and subsequent inhibition of release of active enzymes from
lysosomes.
WBC procedures cause the decrease in level of inflam-
matory state parameters; among others are erythrocyte
sedimentation rate (ESR) value, serum concentration of
C-reactive protein (CRP), fibrinogen, seromucoid, sICAM
(soluble intercellular adhesion molecule), proinflammatory
cytokines IL-1, IL-2, IL-6, and IL-8 levels, and increase in anti-
inflammatory cytokine IL-10 level [22, 34–36].
The other mechanism of anti-inflammatory action of
WBC procedures could be related to its beneficial influ-
ence on prooxidant-antioxidant balance. It is suggested that
repeated exposures to cryogenic temperatures may cause
adaptative changes in the form of an increase in antioxidant
status and antioxidant enzyme activity, resulting in the for-
mation of a prooxidant-antioxidant balance at a higher level,
assisting in an anti-inflammatory effect and protecting tissues
against an increased generation of reactive oxygen species
and oxidative stress caused by training [37–39]. In our own
study in AS patients after ten treatments we also observed the
beneficial influence ofWBCprocedures on antioxidant status
(increased activity of superoxide dismutase, level of total
antioxidant status, and decreased level of malondialdehyde)
[20].
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Figure 5: Comparison of modified Schober test (cm) before and after a cycle of whole-body cryotherapy (WBC) with subsequent
kinesiotherapy procedures (a), before and after only a cycle of kinesiotherapy procedures (b), and Schober test change in whole-body
cryotherapy and kinesiotherapy groups (c) obtained for patients suffering from AS.
The other mechanisms of anti-inflammatory action of
whole-body cryotherapy may be linked to stabilization of
lysosome membranes and subsequent inhibition of release
of active enzymes from lysosomes [40]. It seems that this
effect could be related to increased ACTH and cortisone
blood concentrations, due to bothWBCand physical training
[41, 42].
The obtained results may be also connected with neu-
romuscular effect of cryotherapy which results in reduction
of muscular tone (reduction of nerve transmission and
reactivity of peripheral nerve endings) and increase ofmuscle
strength [10, 29, 30].
The other effect of WBC which may have influence on
achieved results is antioedematous action. This mechanism
results in improvement in patency of lymphatic vessels
draining intercellular space and increase in capillary filtration
and acceleration of lymph flow [11].
Through these aforementioned mechanisms of WBC
procedures, we can observe much better results compared to
kinesiotherapy procedures used separately. WBC preceding
kinesiotherapy allows intensification of the training and
extension of the time of its duration several times [30].
Therefore, procedures of WBC and therapeutic exercises are
altogether main components of the so-called cryorehabilita-
tion [43–45].
In addition, observed calming and nervous tension
reduction in AS patients after WBC treatment may increase
the mobilization of patients to exercise and improve cooper-
ation with the doctor and physiotherapeutist [31].
As authors’ own experience and literature data show,
WBC is well tolerated by patients, including children and the
elderly. During the first days of procedure, there may occur
slight aggravation of disease symptoms which is a generally
promising prognosis. Patients admitted for the whole-body
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Figure 6: Comparison of chest expansion test (cm) before and after a cycle of whole-body cryotherapy with subsequent kinesiotherapy
procedures (a), before and after only a cycle of kinesiotherapy procedures (b), and chest expansion test change in whole-body cryotherapy
and kinesiotherapy groups (c) obtained for patients suffering from AS.
cryotherapy are instructed how to behave during the pro-
cedure. Special attention is paid to the way of breathing in
the proper chamber during the procedure. Inhaling should
be two times shorter than exhaling due to decompression of
cooled air in lungs. Noncompliance with the recommenda-
tion may lead to serious breathing depression. Moreover, it is
forbidden to touch other patients or rub own skin. In addition
each time before WBC procedure patients should dry their
skin with towel in order to remove sweat, as sweat drops turn
into ice crystals in a cryochamber and it may lead to frostbite
[11].
Our study has some limitations. First, the study did not
provide long-term followup (e.g., 3 months), and thus we do
not knowhow long the effect of whole-body cryotherapywith
subsequent kinesiotherapywould bemaintained after the end
of study. Secondly, a cycle of whole-body cryotherapy (WBC)
with a subsequent kinesiotherapy consisted of ten procedures
only. A greater number of procedures (e.g., 20–30) might
increase a treatment effect.
5. General Conclusion
In the present report, we demonstrated that whole-body cry-
otherapy procedures have beneficial influence on AS patients
through decrease of BASDAI andBASFI index, pain intensity,
and improvement of some spinal mobility parameters.
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